Journal Home
Search for

Articles in Press

Return to articles in press list

Initial experience with percutaneous selective embolization: A truly minimally invasive treatment of the adolescent varicocele with no risk of hydrocele development

Douglas W. StormaCorresponding Author Informationemail address, Mark J. Hoganb, Venkata R. Jayanthia

Received 19 September 2009; accepted 6 January 2010. published online 12 February 2010.
Corrected Proof

Abstract 

Objective

Postoperative hydrocele development is a frustrating complication of varicocele surgical repair. To avoid this complication, we began to offer percutaneous embolization as a treatment option. We present our initial experience with this technique.

Methods

A retrospective review of all patients who underwent percutaneous embolization and sclerotherapy of a varicocele at our institution was performed.

Results

There were 27 patients with a mean age of 16 years (range 13–19 years). Indications included pain (48%), varicocele size (30%) and persistent testicular asymmetry (22%). Four patients had experienced failure of a previous surgical repair. Follow-up data were available for 21 patients (mean 9 months). The varicocele resolved in 19 patients (91%) with no evidence of hydrocele formation in any of the boys. There was resolution of pain in all patients for whom this was the indication for the procedure. In the two failures, access to the lower spermatic vein was not possible owing to the number and tortuosity of the vessels.

Conclusions

Percutaneous embolization and sclerotherapy represent a truly minimally invasive treatment with low morbidity, minimal pain and rapid recovery. In our early experience, since lymphatic channels are completely avoided, there appears to be no risk of hydrocele formation.

a Nationwide Children's Hospital, Department of Urology, 700 Children's Drive, G280, Timken Hall, Columbus, OH 43205, United States

b Nationwide Children's Hospital, Department of Radiology, 700 Children's Drive, Columbus, OH 43205, United States

Corresponding Author InformationCorresponding author. Tel.: +1 614 722 6625; fax: +1 614 722 6627.

PII: S1477-5131(10)00006-9

doi:10.1016/j.jpurol.2010.01.003